papaverine has been researched along with 6-ketoprostaglandin f1 alpha in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (42.86) | 18.7374 |
1990's | 4 (57.14) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lonigro, AJ; Sprague, RS; Stephenson, AH; Wurtz, MM | 1 |
Andersson, D; Bergqvist, D; Brunkwall, JS; Jackson, T; Stanley, JC | 1 |
Blasevich, M; Borghi, A; Galli, C; Petroni, A; Socini, A | 1 |
Borghi, A; Galli, C; Petroni, A | 1 |
Alexander, JA; Faro, RS; Hay, DA; Knauf, DG; Mehta, JL; Mehta, P; Roberts, AJ; Roy, L | 1 |
Chang, WC; Lin, JS; Lui, SM | 1 |
Cooper, GJ; Gillot, T; Kennedy, A; Parry, EA; Wilkinson, GA | 1 |
7 other study(ies) available for papaverine and 6-ketoprostaglandin f1 alpha
Article | Year |
---|---|
Enhanced microvascular permeability of PMA-induced acute lung injury is not mediated by cyclooxygenase products.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Capillary Permeability; Dogs; In Vitro Techniques; Indomethacin; Leukocyte Count; Lung Diseases; Male; Methacrylates; Papaverine; Prostaglandin-Endoperoxide Synthases; Tetradecanoylphorbol Acetate; Thromboxane A2; Thromboxane B2; Thromboxane-A Synthase | 1992 |
Papaverine effects on PGI2 and TXA2 release from the canine vascular wall.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Carotid Arteries; Chromatography, High Pressure Liquid; Dogs; Epoprostenol; Jugular Veins; Microscopy, Electron, Scanning; Muscle, Smooth, Vascular; Papaverine; Perfusion; Secretory Rate; Thromboxane A2; Thromboxane B2 | 1992 |
Differential effects of various vasoactive drugs on basal and stimulated levels of TXB2 and 6-keto-PGF1 alpha in rat brain.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Brain; Dipyridamole; Male; Microwaves; Nifedipine; Papaverine; Rats; Thromboxane B2; Thromboxanes; Vasomotor System | 1985 |
Modification of brain vascular eicosanoids after pharmacological treatment and ischemia in the rat: drugs and brain vascular eicosanoids.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Brain Ischemia; Cerebral Cortex; Chromonar; Eicosanoic Acids; Papaverine; Rats; Thromboxane B2; Thromboxanes; Vasodilator Agents | 1985 |
Biochemical and ultrastructural integrity of the saphenous vein conduit during coronary artery bypass grafting. Preliminary results of the effect of papaverine.
Topics: 6-Ketoprostaglandin F1 alpha; Coronary Artery Bypass; Drug Evaluation; Epoprostenol; Gluconates; Humans; In Vitro Techniques; Intraoperative Care; Isotonic Solutions; Magnesium Chloride; Microscopy, Electron, Scanning; Papaverine; Potassium Chloride; Saphenous Vein; Sodium Acetate; Sodium Chloride; Time Factors | 1984 |
The change of penile blood thromboxane B2 and prostacyclin after intracavernous injection of vasoactive drugs for the treatment of arteriogenic impotence.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aged; Alprostadil; Diabetes Complications; Epoprostenol; Erectile Dysfunction; Humans; Hypertension; Male; Middle Aged; Papaverine; Penis; Phentolamine; Radioimmunoassay; Thromboxane B2 | 1994 |
Papaverine injures the endothelium of the internal mammary artery.
Topics: 6-Ketoprostaglandin F1 alpha; Endothelium, Vascular; Epoprostenol; Humans; Hydrogen-Ion Concentration; In Vitro Techniques; Mammary Arteries; Papaverine | 1995 |